Tactogen

Tactogen
Company typePublic benefit corporation
IndustryPharmaceutical; Psychedelic medicine
Founded2020 (2020) in Palo Alto, United States
FounderMatthew J. Baggott; Luke Pustejovsky
Headquarters
Palo Alto, California
,
United States
Websitetactogen.com

Tactogen is a public benefit corporation and start-up pharmaceutical company based in Palo Alto, California that is developing novel MDMA-like entactogens and psychedelics as medicines. Its stated goal is to develop new MDMA-like drugs with improved effectiveness, tolerability, and safety, as well as gentleness and accessibility, for treatment of psychiatric disorders and other conditions. Tactogen was co-founded by neuroscientist Matthew J. Baggott and Luke Pustejovsky in 2020. Baggott is the chief executive officer (CEO) while Pustejovsky is the chief operating officer (COO).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.